J W Stewart

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. doi request reprint Combination antidepressant therapy for major depressive disorder: Speed and probability of remission
    Jonathan W Stewart
    Columbia University College of Physicians and Surgeons, New York, NY, USA New York State Psychiatric Institute, New York, NY, USA Electronic address
    J Psychiatr Res 52:7-14. 2014
  2. ncbi request reprint Do age of onset and course of illness define biologically distinct groups within atypical depression?
    Jonathan W Stewart
    Department of Therapeutics, New York State Psychiatric Institute and Columbia University College of Physicians and Surgeons, USA
    J Abnorm Psychol 112:253-62. 2003
  3. ncbi request reprint Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions
    Jonathan W Stewart
    New York State Psychiatric Institute, United States Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA
    J Affect Disord 86:161-7. 2005
  4. ncbi request reprint Treating depression with atypical features
    Jonathan W Stewart
    Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA
    J Clin Psychiatry 68:25-9. 2007
  5. doi request reprint Is duloxetine effective treatment for depression with atypical features?
    Jonathan W Stewart
    New York State Psychiatric Institute, Columbia University College of Physicians and Surgeons, New York, New York, USA
    Int Clin Psychopharmacol 23:333-6. 2008
  6. doi request reprint Do atypical features affect outcome in depressed outpatients treated with citalopram?
    Jonathan W Stewart
    New York State Psychiatric Institute and Department of Psychiatry, The College of Physicians and Surgeons of Columbia University, New York, NY, USA
    Int J Neuropsychopharmacol 13:15-30. 2010
  7. doi request reprint DSM-IV depression with atypical features: is it valid?
    Jonathan W Stewart
    Department of Depression Evaluation Service, New York State Psychiatrist Institute, New York, NY 10032, USA
    Neuropsychopharmacology 34:2625-32. 2009
  8. doi request reprint Does dual antidepressant therapy as initial treatment hasten and increase remission from depression?
    Jonathan W Stewart
    New York State Psychiatric Institute and Columbia University College of Physicians and Surgeons, New York, USA
    J Psychiatr Pract 15:337-45. 2009
  9. ncbi request reprint Atypical features and treatment response in the National Institute of Mental Health Treatment of Depression Collaborative Research Program
    J W Stewart
    New York State Psychiatric Institute, New York, USA
    J Clin Psychopharmacol 18:429-34. 1998
  10. ncbi request reprint Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission
    J W Stewart
    New York State Psychiatric Institute, N Y, USA
    Am J Psychiatry 154:31-6. 1997

Research Grants

Detail Information

Publications57

  1. doi request reprint Combination antidepressant therapy for major depressive disorder: Speed and probability of remission
    Jonathan W Stewart
    Columbia University College of Physicians and Surgeons, New York, NY, USA New York State Psychiatric Institute, New York, NY, USA Electronic address
    J Psychiatr Res 52:7-14. 2014
    ..This study tested whether combining escitalopram and bupropion as initial treatment would result in quicker remission and a higher remission rate than monotherapy with either drug...
  2. ncbi request reprint Do age of onset and course of illness define biologically distinct groups within atypical depression?
    Jonathan W Stewart
    Department of Therapeutics, New York State Psychiatric Institute and Columbia University College of Physicians and Surgeons, USA
    J Abnorm Psychol 112:253-62. 2003
    ..Course of illness may usefully define more homogeneous depressive subgroups within atypical depression...
  3. ncbi request reprint Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions
    Jonathan W Stewart
    New York State Psychiatric Institute, United States Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA
    J Affect Disord 86:161-7. 2005
    ....
  4. ncbi request reprint Treating depression with atypical features
    Jonathan W Stewart
    Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA
    J Clin Psychiatry 68:25-9. 2007
    ..Despite advances in agents for melancholic depression, treatment for atypical depression remains dependent upon older agents for the greatest efficacy...
  5. doi request reprint Is duloxetine effective treatment for depression with atypical features?
    Jonathan W Stewart
    New York State Psychiatric Institute, Columbia University College of Physicians and Surgeons, New York, New York, USA
    Int Clin Psychopharmacol 23:333-6. 2008
    ..Placebo-controlled studies are required to definitively demonstrate whether these pilot results represent the efficacy of duloxetine in treating atypical depression...
  6. doi request reprint Do atypical features affect outcome in depressed outpatients treated with citalopram?
    Jonathan W Stewart
    New York State Psychiatric Institute and Department of Psychiatry, The College of Physicians and Surgeons of Columbia University, New York, NY, USA
    Int J Neuropsychopharmacol 13:15-30. 2010
    ..Depressed patients with atypical features are less likely to remit with citalopram than those without atypical features. This finding is probably due to differences in baseline characteristics other than atypical symptom features...
  7. doi request reprint DSM-IV depression with atypical features: is it valid?
    Jonathan W Stewart
    Department of Depression Evaluation Service, New York State Psychiatrist Institute, New York, NY 10032, USA
    Neuropsychopharmacology 34:2625-32. 2009
    ....
  8. doi request reprint Does dual antidepressant therapy as initial treatment hasten and increase remission from depression?
    Jonathan W Stewart
    New York State Psychiatric Institute and Columbia University College of Physicians and Surgeons, New York, USA
    J Psychiatr Pract 15:337-45. 2009
    ..Only 30%-40% of depressed patients remit after 8 weeks of treatment with an antidepressant. We hypothesized that beginning treatment with two antidepressants would improve remission rates...
  9. ncbi request reprint Atypical features and treatment response in the National Institute of Mental Health Treatment of Depression Collaborative Research Program
    J W Stewart
    New York State Psychiatric Institute, New York, USA
    J Clin Psychopharmacol 18:429-34. 1998
    ..Failure to identify this subtype underestimates imipramine's benefit in the appropriately treated subgroup. Comparisons of other treatments with imipramine may be misleading if they do not account for diagnostic subtype...
  10. ncbi request reprint Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission
    J W Stewart
    New York State Psychiatric Institute, N Y, USA
    Am J Psychiatry 154:31-6. 1997
    ..Demonstration of antidepressant efficacy beyond 6 months has infrequently been addressed, and no long-term efficacy data exist for patients with chronic atypical depression...
  11. ncbi request reprint A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression
    P J McGrath
    New York State Psychiatric Institute, Columbia University College of Physicians and Surgeons, New York, NY 10032 2695, USA
    Am J Psychiatry 157:344-50. 2000
    ..The objective of this study was to estimate the efficacy of the selective serotonin reuptake inhibitor (SSRI) fluoxetine in the treatment of major depression with atypical features...
  12. ncbi request reprint Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression
    P J McGrath
    Department of Psychiatry, Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute, New York, USA
    J Clin Psychiatry 61:518-24. 2000
    ..The goal was to examine predictors of relapse during continuation/maintenance treatment of major depression that had remitted following 12 to 14 weeks of fluoxetine therapy...
  13. ncbi request reprint Antidepressant specificity in atypical depression
    M R Liebowitz
    Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY
    Arch Gen Psychiatry 45:129-37. 1988
    ..This is consonant with some but not other recent findings and requires replication. Overall, the concept of atypical depression as a subtype that is preferentially responsive to monoamine oxidase inhibitors is supported...
  14. ncbi request reprint Outcome of cognitive-behavioral therapy for depression: relation to hemispheric dominance for verbal processing
    G E Bruder
    Department of Biopsychology, New York State Psychiatric Institute, New York 10032, USA
    J Abnorm Psychol 106:138-44. 1997
    ..The findings suggest that greater left-hemisphere advantage for verbal processing is associated with more favorable outcome of cognitive therapy for depression...
  15. ncbi request reprint Remission rates with 3 consecutive antidepressant trials: effectiveness for depressed outpatients
    Frederic M Quitkin
    Department of Therapeutics, Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, New York, USA
    J Clin Psychiatry 66:670-6. 2005
    ..This effectiveness study assessed remission rates in patients who had the opportunity to receive up to 3 antidepressant trials if unresponsive...
  16. doi request reprint Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine
    Huaiyu Yang
    Department of Psychiatry, Depression Clinical and Research Program at Massachusetts General Hospital, Harvard Medical School, 15 Parkman Street, Boston, MA 02114, USA
    Eur Arch Psychiatry Clin Neurosci 260:145-50. 2010
    ..Limitations: (1) limited generalizability due to inclusion/exclusion criteria; (2) lack of active comparator treatment group; (3) post hoc analysis...
  17. ncbi request reprint Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design
    S J Donovan
    Department of Therapeutics, Division of Epidemiology of Brain Disorders, New York State Psychiatric Institute, New York, NY 10032, USA
    Am J Psychiatry 157:818-20. 2000
    ..The authors sought to replicate open-label findings showing that specific criteria for explosive temper and mood lability identify disruptive youth who improve while receiving the anticonvulsant divalproex sodium...
  18. ncbi request reprint Do age of onset and course of illness predict different treatment outcome among DSM IV depressive disorders with atypical features?
    Jonathan W Stewart
    New York State Psychiatric Institute, New York, NY 10032, USA
    Neuropsychopharmacology 26:237-45. 2002
    ..Findings suggest that application of DSM IV atypical features might best be limited to those with early onset of chronic dysphoria...
  19. ncbi request reprint Atypical and non-atypical subtypes of depression: comparison of social functioning, symptoms, course of illness, co-morbidity and demographic features
    V Agosti
    New York State Psychiatric Institute and the Department of Psychiatry, Columbia University College of Physicians and Surgeons, NY 10032, USA
    J Affect Disord 65:75-9. 2001
    ..There are scant data regarding the demographic and psychosocial characteristics of outpatients with Atypical Depression (AD)...
  20. ncbi request reprint Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: effects on personality
    D J Hellerstein
    Outpatient Mental Health Services, Beth Israel Medical Center, New York, NY 10003, USA
    Am J Psychiatry 157:1436-44. 2000
    ....
  21. ncbi request reprint Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9086, USA
    Control Clin Trials 25:119-42. 2004
    ..Participants with an adequate symptomatic response may enter the 12-month naturalistic follow-up phase with brief monthly and more complete quarterly assessments...
  22. ncbi request reprint Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 9086, USA
    Am J Psychiatry 163:1905-17. 2006
    ..This report describes the participants and compares the acute and longer-term treatment outcomes associated with each of four successive steps in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial...
  23. ncbi request reprint Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D
    Jon S Novick
    Zucker Hillside Hospital, Glen Oaks, NY, USA
    J Clin Psychiatry 66:1002-11. 2005
    ..To determine the frequency and demographic and clinical characteristics of depression with atypical features in a broadly representative sample of outpatients...
  24. ncbi request reprint Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report
    Diane Warden
    Department of Psychiatry, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 9086, USA
    Am J Psychiatry 164:1189-97. 2007
    ..The purpose of this study was to identify the pretreatment predictors of attrition during acute treatment with citalopram in a large, "real world" clinical trial...
  25. ncbi request reprint Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 9086, USA
    N Engl J Med 354:1231-42. 2006
    ..After unsuccessful treatment for depression with a selective serotonin-reuptake inhibitor (SSRI), it is not known whether switching to one antidepressant is more effective than switching to another...
  26. ncbi request reprint Electroencephalographic and perceptual asymmetry differences between responders and nonresponders to an SSRI antidepressant
    G E Bruder
    Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York, USA
    Biol Psychiatry 49:416-25. 2001
    ....
  27. ncbi request reprint Somatization as a predictor of medication discontinuation due to adverse events
    V Agosti
    New York State Psychiatric Institute, New York 10032, USA
    Int Clin Psychopharmacol 17:311-4. 2002
    ....
  28. doi request reprint Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study
    Sidney Zisook
    Department of Psychiatry, University of California, San Diego, San Diego VA Medical Center, San Diego, California, USA
    J Affect Disord 117:63-73. 2009
    ..The purpose of this study was to determine whether, and in whom, treatment of MDD is associated with increased or emergent SI...
  29. ncbi request reprint Effect of age at onset on the course of major depressive disorder
    Sidney Zisook
    Department of Psychiatry, University of California, San Diego, CA 92093, USA
    Am J Psychiatry 164:1539-46. 2007
    ..This report assesses whether age at onset defines a specific subgroup of major depressive disorder in 4,041 participants who entered the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study...
  30. pmc EEG hemispheric asymmetries during cognitive tasks in depressed patients with high versus low trait anxiety
    Carlye B G Manna
    Division of Cognitive Neuroscience, New York State Psychiatric Institute, New York, NY 10032, USA
    Clin EEG Neurosci 41:196-202. 2010
    ..These results are consistent with Heller's two-dimensional model of depression and anxiety and highlight the sensitivity of task-related EEG alpha in discriminating among subgroups of depressed patients differing in trait anxiety...
  31. ncbi request reprint Efficacy and safety of antidepressant monotherapy in the treatment of bipolar-II depression
    Vito Agosti
    New York State Psychiatric Institute and Columbia College of Physicians and Surgeons, 1051 Riverside Drive, New York, NY 10032, USA
    Int Clin Psychopharmacol 22:309-11. 2007
    ..No patient developed manic symptoms that required medication discontinuation or mood stabilizer augmentation. Antidepressant monotherapy was found to be a safe and effective treatment for bipolar-II depression...
  32. pmc Hemispatial PCA dissociates temporal from parietal ERP generator patterns: CSD components in healthy adults and depressed patients during a dichotic oddball task
    Craig E Tenke
    Division of Cognitive Neuroscience, New York State Psychiatric Institute, New York, NY 10032, USA
    Int J Psychophysiol 67:1-16. 2008
    ..Results are consistent with prior reports of P3 reduction in depression and implicate distinct parietal and temporal generators of P3 when using a dichotic oddball paradigm...
  33. ncbi request reprint Hypomania with and without Dysphoria: comparison of comorbidity and clinical characteristics of respondents from a national community sample
    Vito Agosti
    New York State Psychiatric Institute, 1051 Riverside Drive, 10965, New York, NY, United States
    J Affect Disord 108:177-82. 2008
    ..To compare rates of comorbidity, treatment utilization, the course of illness, and past year social functioning of Hypomania with and without Dysphoria Hypomania (mixed state)...
  34. pmc Reduced brain responses to novel sounds in depression: P3 findings in a novelty oddball task
    Gerard E Bruder
    Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Psychiatry Res 170:218-23. 2009
    ..Nor was there a group difference in the earlier N1 or N2 potentials. The novelty P3 reduction in depressed patients is indicative of a deficit in orienting of attention and evaluation of novel environmental sounds...
  35. pmc Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings
    Gerard E Bruder
    Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, New York, USA
    Biol Psychiatry 63:1171-7. 2008
    ....
  36. pmc Neuropsychological characteristics as predictors of SSRI treatment response in depressed subjects
    Marianne Gorlyn
    Department of Neuroscience, New York State Psychiatric Institute, New York, NY, USA
    J Neural Transm 115:1213-9. 2008
    ..Cognitive slowing may mediate the working memory and executive function deficits found in nonresponders. These findings can inform exploration for pharmacogenetic endophenotypes...
  37. doi request reprint Does personality disorder decrease the likelihood of remission in early-onset chronic depression?
    Vito Agosti
    Department of Psychiatry, New York State Psychiatric Institute, New York, NY 10032, USA
    Compr Psychiatry 50:491-5. 2009
    ..Elevated rates of PD have been noted in early-onset and chronic forms subtypes of depression. However, scant data exist regarding the link between PD and outcome for this depression subtype...
  38. ncbi request reprint Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report
    Patrick J McGrath
    Department of Psychiatry, College of Physicians and Surgeons of Columbia University and New York State Psychiatric Institute, New York, NY 10032, USA
    J Clin Psychiatry 69:1847-55. 2008
    ....
  39. pmc Predicting therapeutic response to secondary treatment with bupropion: dichotic listening tests of functional brain asymmetry
    Gerard E Bruder
    Department of Psychiatry, Columbia University College of Physicians and Surgeons and New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, United States
    Psychiatry Res 153:137-43. 2007
    ....
  40. ncbi request reprint Left hemisphere dysfunction during verbal dichotic listening tests in patients who have social phobia with or without comorbid depressive disorder
    Gerard E Bruder
    Department of Biopsychology, New York Psychiatric Institute, New York 10032, USA
    Am J Psychiatry 161:72-8. 2004
    ..The present study used dichotic listening tests to assess lateralized cognitive processing in patients with social phobia, depression, or comorbid social phobia and depression...
  41. pmc Novelty P3 reductions in depression: characterization using principal components analysis (PCA) of current source density (CSD) waveforms
    Craig E Tenke
    Division of Cognitive Neuroscience, New York State Psychiatric Institute, New York, NY 10032, USA
    Psychophysiology 47:133-46. 2010
    ..Compatible CSD-PCA findings were also confirmed for the original low-density sample. Results are consistent with a reduced novelty response in clinical depression, involving the early phase of the frontocentral novelty P3...
  42. ncbi request reprint Dichotic listening tests of functional brain asymmetry predict response to fluoxetine in depressed women and men
    Gerard E Bruder
    Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Neuropsychopharmacology 29:1752-61. 2004
    ..Responder vs nonresponder differences for verbal dichotic listening in women and nonverbal dichotic listening in men are discussed in terms of differences in cognitive function, hemispheric organization, and neurotransmitter function...
  43. ncbi request reprint Are there differences between women's and men's antidepressant responses?
    Frederic M Quitkin
    Department of Therapeutics, New York State Psychiatric Institute and Columbia University College of Physicians and Surgeons, New York 10032, USA
    Am J Psychiatry 159:1848-54. 2002
    ..The study examined a large data set to determine whether patients' sex affected the outcome of antidepressant treatment...
  44. ncbi request reprint Cognitive ERPs in depressive and anxiety disorders during tonal and phonetic oddball tasks
    Gerard E Bruder
    Department of Biopsychology, New York State Psychiatric Institute, Unit 50, 1051 Riverside Drive, New York, NY 10032, USA
    Clin Electroencephalogr 33:119-24. 2002
    ....
  45. ncbi request reprint Atypical depression: enhanced right hemispheric dominance for perceiving emotional chimeric faces
    Gerard E Bruder
    Department of Biopsychology, New York State Psychiatric Institute, New York 10032, USA
    J Abnorm Psychol 111:446-54. 2002
    ..This is further evidence that atypical depression is a biologically distinct subtype and underscores the importance of this diagnostic distinction for neurophysiologic studies...
  46. ncbi request reprint Psychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients
    Bonnie P Taylor
    Depression Evaluation Service, New York State Psychiatric Institute, Department of Psychiatry, Columbia University College of Physicians and Surgeons, 1051 Riverside Dr, New York, NY 10032, USA
    Am J Psychiatry 163:73-8. 2006
    ..The authors hypothesized that since psychomotor slowing in depressed patients has been linked to reduced dopaminergic neurotransmission, patients with slowing would be unresponsive to fluoxetine, a selective serotonin reuptake inhibitor...
  47. ncbi request reprint Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report
    Patrick J McGrath
    Depression Evaluation Service, New York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032, USA
    Am J Psychiatry 163:1531-41; quiz 1666. 2006
    ....
  48. ncbi request reprint Predictors of relapse in a prospective study of fluoxetine treatment of major depression
    Patrick J McGrath
    Depression Evaluation Service, New York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032 1007, USA
    Am J Psychiatry 163:1542-8. 2006
    ..This study was designed to test the predictive value of response pattern prospectively and to examine the data for other predictors of relapse...
  49. ncbi request reprint Treating DSM-IV depression with atypical features
    Jonathan W Stewart
    Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA
    J Clin Psychiatry 68:e10. 2007
    ..Following this presentation is a discussion on the treatment of depression with atypical features by experts in this subject area...
  50. ncbi request reprint Perceptual asymmetry differences between major depression with or without a comorbid anxiety disorder: a dichotic listening study
    G E Bruder
    Department of Biopsychology, New York State Psychiatric Institute, New York 10032, USA
    J Abnorm Psychol 108:233-9. 1999
    ..Patients having an anxious depression appear to have a greater propensity to activate right than left-hemisphere regions during auditory tasks, whereas those having a nonanxious depression have the opposite hemispheric asymmetry...
  51. ncbi request reprint Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care
    Madhukar H Trivedi
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA
    Neuropsychopharmacology 32:2479-89. 2007
    ..This approach signals a paradigm shift toward the use of measurement-based clinical decisions, both at the point of care and following each visit, to deliver optimal pharmacotherapy for depression...
  52. ncbi request reprint "Outer-directed irritability": a distinct mood syndrome in explosive youth with a disruptive behavior disorder?
    Stephen J Donovan
    Department of Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA
    J Clin Psychiatry 64:698-701. 2003
    ....
  53. ncbi request reprint Controlled trial of bright light and negative air ions for chronic depression
    Namni Goel
    Department of Psychology, 207 High Street, Judd Hall, Wesleyan University, Middletown, CT 06459, USA
    Psychol Med 35:945-55. 2005
    ..Both methods have shown clinical success for seasonal affective disorder (SAD)...
  54. ncbi request reprint Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences
    Louis S Matza
    MEDTAP International, Inc, Bethesda, MD 20814, USA
    Arch Gen Psychiatry 60:817-26. 2003
    ..The current study was conducted to increase understanding of atypical depression diagnosed using only the reversed vegetative symptoms of hypersomnia and hyperphagia...
  55. ncbi request reprint A reappraisal of atypical depression
    Frederic M Quitkin
    Am J Psychiatry 160:798-800; author reply 800-1. 2003
  56. ncbi request reprint Accurate meta-analytical assessment of "true antidepressant effects" needed
    Frederic M Quitkin
    J Clin Psychiatry 66:1192; author reply 1192-3. 2005
  57. ncbi request reprint Do antihypertensives make tranylcypromine safer? Three case reports
    Bonnie P Taylor
    J Clin Psychiatry 66:657-8. 2005

Research Grants4